Results
eNauka >
Rezultati >
HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction
| Naziv: | HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction | Autori  : | Maglakelidze, Marina; ...; Andric, Zoran G   ; Nikolic, Ivan V ; ...; Radosavljevic, Davorin Z ; Petrovic, Zeljko M; ...; (broj, koautora 16) |
Godina: | 2021 | Publikacija: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Pretraži identifikator |
Tip rezultata: | Konferencijski rad | Kolacija: | vol. 32 br. Suppl 3 str. S154-S154 | DOI: | 10.1016/j.annonc.2021.05.214 | WoS-ID: | 000670004200158 | URI: | https://enauka.gov.rs/handle/123456789/805539 | Projekat: | Imugene Limited | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | Napomena: | 23rd ESMO World Congress on Gastrointestinal Cance, ELECTR NETWORK, JUN 30-JUL 03, 2021 | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.